Department of General Surgery, Gansu Provincial Central Hospital, Lanzhou, 730050, China; The First Clinical Medical College, Gansu University of Chinese Medicine, Lanzhou, 730000, China.
Department of General Surgery, Gansu Provincial Central Hospital, Lanzhou, 730050, China.
Asian J Surg. 2024 Feb;47(2):886-892. doi: 10.1016/j.asjsur.2023.10.036. Epub 2023 Oct 23.
There is ongoing debate about whether intraoperative parathyroid autotransplantation effectively prevents permanent hypoparathyroidism after thyroidectomy. This study aims to examine its impact on postoperative parathyroid function and determine the best autotransplantation strategy.
A retrospective analysis was conducted on 194 patients who underwent total thyroidectomy with central lymph node dissection (CLND) for papillary thyroid carcinoma (PTC). Patients were divided into four groups based on the number of parathyroid autotransplants during surgery: Group 1 (none, n = 43), Group 2 (1 transplant, n = 60), Group 3 (2 transplants, n = 67), and Group 4 (3 transplants, n = 24). Various clinical parameters were collected and compared among the groups.
Parathyroid autotransplantation was identified as a risk factor for temporary hypoparathyroidism (OR: 1.74; 95% CI: 1.27-2.39, P = 0.001) and a protective factor for permanent hypoparathyroidism (OR: 0.27; 95% CI: 0.14-0.55, P < 0.001). At 12 months postoperative, systemic parathyroid hormone (PTH) levels increased progressively from Groups 1 to 4, with significant differences observed only between Group 1 and Group 2 (P < 0.02). Difference values in systemic PTH levels between Month 1 and Day 1 postoperative increased progressively from Groups 1 to 4, with statistically significant differences observed between adjacent groups (P < 0.02). The number of dissected positive lymph nodes increased progressively across the four groups, showing statistical differences (P < 0.02).
Parathyroid autotransplantation can prevent permanent hypoparathyroidism. Additionally, we recommend preserving parathyroids in situ whenever possible. If autotransplantation is required, it should involve no more than two glands.
关于甲状旁腺自体移植是否能有效预防甲状腺切除术后永久性甲状旁腺功能减退症,目前仍存在争议。本研究旨在探讨其对术后甲状旁腺功能的影响,并确定最佳的自体移植策略。
回顾性分析了 194 例行全甲状腺切除术和中央淋巴结清扫术(CLND)治疗甲状腺乳头状癌(PTC)的患者。根据手术中甲状旁腺自体移植的数量,患者分为 4 组:第 1 组(无移植,n=43)、第 2 组(1 次移植,n=60)、第 3 组(2 次移植,n=67)和第 4 组(3 次移植,n=24)。收集各组的各种临床参数并进行比较。
甲状旁腺自体移植被确定为暂时性甲状旁腺功能减退的危险因素(OR:1.74;95%CI:1.27-2.39,P=0.001)和永久性甲状旁腺功能减退的保护因素(OR:0.27;95%CI:0.14-0.55,P<0.001)。术后 12 个月,系统甲状旁腺激素(PTH)水平从第 1 组到第 4 组逐渐升高,仅第 1 组和第 2 组之间存在显著差异(P<0.02)。第 1 组和第 2 组之间的系统 PTH 水平的差值从第 1 组到第 4 组逐渐升高,相邻组之间存在统计学差异(P<0.02)。四个组中阳性淋巴结的检出数量逐渐增加,具有统计学差异(P<0.02)。
甲状旁腺自体移植可以预防永久性甲状旁腺功能减退症。此外,我们建议尽可能保留原位甲状旁腺。如果需要自体移植,建议不超过两个腺体。